Ning-Fang Ma

3.2k total citations
9 papers, 514 citations indexed

About

Ning-Fang Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ning-Fang Ma has authored 9 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Ning-Fang Ma's work include RNA modifications and cancer (2 papers), Polyamine Metabolism and Applications (2 papers) and Epigenetics and DNA Methylation (2 papers). Ning-Fang Ma is often cited by papers focused on RNA modifications and cancer (2 papers), Polyamine Metabolism and Applications (2 papers) and Epigenetics and DNA Methylation (2 papers). Ning-Fang Ma collaborates with scholars based in China, Hong Kong and United States. Ning-Fang Ma's co-authors include Dan Xie, Xin‐Yuan Guan, Liang Hu, Qiu-Liang Wu, Yan Fang, Jonathan S. T. Sham, Li Fu, Yi Wang, Sze Hang Lau and Mengsu Yang and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Stem Cells.

In The Last Decade

Ning-Fang Ma

9 papers receiving 509 citations

Peers

Ning-Fang Ma

MB

CR

EPIDE

ONCOL

HEPAT

Felix H. Shek Hong Kong

G Y Chau Taiwan

Te-Sheng Chang Taiwan

Xiaochuan Dong China

Yoshihiko Kishima Japan

Irene Lo China

Meng‐Chao Wu China

Lihui Zhu China

Cui Tan China

Yan Stein Israel

Felix H. Shek Hong Kong

Ning-Fang Ma

347 ×1.0

MB

249 ×1.9

CR

43 ×0.3

EPIDE

57 ×0.6

ONCOL

32 ×0.4

HEPAT

Citations per year, relative to Ning-Fang Ma Ning-Fang Ma (= 1×) peers Felix H. Shek

Countries citing papers authored by Ning-Fang Ma

Since Specialization

Citations

This map shows the geographic impact of Ning-Fang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning-Fang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning-Fang Ma more than expected).

Fields of papers citing papers by Ning-Fang Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning-Fang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning-Fang Ma. The network helps show where Ning-Fang Ma may publish in the future.

Co-authorship network of co-authors of Ning-Fang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ning-Fang Ma. A scholar is included among the top collaborators of Ning-Fang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning-Fang Ma. Ning-Fang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Ma, Ning-Fang, et al.. (2019). Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma. International Journal of Gynecological Cancer. 29(8). 1280–1284. 11 indexed citations

2.

Li, Yang, Li-Ru He, Ying Gao, et al.. (2019). CHD1L contributes to cisplatin resistance by upregulating the ABCB1–NF-κB axis in human non-small-cell lung cancer. Cell Death and Disease. 10(2). 99–99. 37 indexed citations

3.

Chen, Xin, Jiaxing Zhang, Junhang Luo, et al.. (2018). CSTF2-Induced Shortening of the RAC1 3′UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder. Cancer Research. 78(20). 5848–5862. 55 indexed citations

4.

Chen, Xin, Xiangdong Li, Gang Yuan, et al.. (2018). TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation. Cancer Letters. 435. 10–22. 64 indexed citations

5.

Liao, Yiji, Mu-Yan Cai, Ning-Fang Ma, et al.. (2017). Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis. Stem Cells. 36(2). 180–191. 26 indexed citations

6.

He, Li-Ru, Ning-Fang Ma, Jie-Wei Chen, et al.. (2015). Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival. Oncotarget. 6(31). 31181–31190. 21 indexed citations

7.

Ma, Ning-Fang, Sze Hang Lau, Liang Hu, et al.. (2008). COOH-Terminal Truncated HBV X Protein Plays Key Role in Hepatocarcinogenesis. Clinical Cancer Research. 14(16). 5061–5068. 132 indexed citations

8.

Xie, Dan, Ning-Fang Ma, Zhi-Zhong Pan, et al.. (2007). Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Human Pathology. 39(1). 80–86. 63 indexed citations

9.

Guan, Xin‐Yuan, Ning-Fang Ma, Dan Xie, et al.. (2004). Oncogenic Role of eIF-5A2 in the Development of Ovarian Cancer. Cancer Research. 64(12). 4197–4200. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact